Article

Paradigm Medical Industries presents early glaucoma detection device

Paradigm Medical Industries Inc. introduced its electrophysiology instrument (Glaid-PERG) for the early detection of glaucoma.

Paradigm Medical Industries Inc. introduced its electrophysiology instrument (Glaid-PERG) forthe early detection of glaucoma.

"All research and studies indicate the [diagnostic device] is the earliest means of detectingcellular losses attributed to glaucoma and other ocular ailments," said Raymond Cannefax,Paradigm Medical's chief executive officer. An agreement was signed earlier this year with LACEElettronica srl, Rome, for the exclusive distribution of the instrument.

The device has provided high-test repeatability and a high level of accuracy in clinicalstudies at major U.S. and European glaucoma centers, as well as universities and researchcenters, the company said. Ongoing research indicates possible testing applications for ocularailments other than glaucoma.

"We are excited about the impact the new instrument will have-not only in our industry, but inmedical benefits to those who will be diagnosed early [with suspected glaucoma]," Cannefaxsaid. "Early diagnosis will help reduce vision loss and help preserve sight."

Paradigm Medical also introduced a prototype version of its redesigned autoperimetry system(LD400). The system measures patient visual fields to determine the severity of glaucoma and toaid in managing the disease.

For more information, visit Paradigm Medical Industries at booth 755.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.